Compare Microsoft (MSFT) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microsoft vs Nuwellis Inc — how do they compare? Microsoft trades at $502.24 (market cap $3.76T), while Nuwellis Inc trades at $1.47 (market cap $522.76K). The key difference: Microsoft is far larger — about 7192593.2× Nuwellis Inc's market cap, and Microsoft pays a 0.72% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MSFT | NUWE | |
|---|---|---|
Market Cap | $3.76T | $522.76K |
Volume | 36,654,621 | — |
Sector | Technology | Technology |
52-Week High | $542.07 | $220.50 |
52-Week Low | $352.83 | $1.42 |
Enterprise Value | $3.74T | -$1.29M |
Dividend Yield | 0.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Microsoft (MSFT) trades at $503.81, up 0.76% on the day, with a bullish technical signal and strong fundamentals. The stock shows robust earnings beats in recent quarters, with Q2 2026 EPS of $4.74 exceeding the $4.24 estimate. Revenue growth is steady, reaching $281.72B in 2025, supported by a net income margin of 40.31%. Analyst consensus is overwhelmingly positive, with 80.49% buy ratings and a $553.70 price target. Recent news highlights AI leadership and Azure momentum, though concerns over capital expenditures persist.
Outlook remains favorable with AI-driven growth and cloud expansion, but risks include high valuation (P/E 28.19) and competitive pressures. Investment opportunity lies in sustained earnings momentum and dividend stability, while volatility from tech sector shifts and macroeconomic factors warrants caution.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
